DATA STORIES
Data stories
Findings from the trial and search data behind the Global Peptide Index, each with its chart and source.
| 10.5% of peptide trials on ClinicalTrials.gov were stopped early | 1,029 of 9,827 registered trials of 60 peptides were terminated, withdrawn or suspended. Read from ClinicalTrials.gov on 2026-09-04. |
|---|---|
| 5 peptides searched over 10,000 times a month in the US have 1 to 5 registered trials | BPC-157, Ipamorelin, MOTS-c, GHK-Cu, CJC-1295: each searched over 10,000 times a month in the US, each with 1 to 5 trials on ClinicalTrials.gov. |
| 2026 has the most new peptide trials registered of any year to 25 August: 466 | 466 new trials of the 60 tracked peptides were registered on ClinicalTrials.gov from 1 January to 25 August 2026, against 394 over the same days of 2025. |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.